ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2026
Nose-to-brain delivery of a SOD1-stabilizing small molecule ameliorates pathology in an ALS mouse model.
Ranjithkumar Dhandapani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.